Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Schipper

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Frontiers in Oncology|December 5, 2019
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck CancerYue Cao, Madhava Aryal, Pin Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2016
Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation StudyMichelle M Kim, Sandra Camelo-Piragua, Matthew Schipper, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 30, 2024
Factors associated with acute esophagitis during radiation therapy for lung cancerDaniel J Herr, Huiying Yin, Derek Bergsma, et al.
JNCI Cancer Spectrum|November 17, 2025
Postprostatectomy prostate cancer treated with radiation therapy: adverse features and androgen deprivation therapy use in a statewide consortiumSamuel N Regan, Michael Dykstra, Huiying Yin, et al.
Practical Radiation Oncology|February 8, 2023
Cardiac and Pulmonary Dosimetric Parameters in Patients With Lung Cancer Undergoing Postoperative Radiation Therapy Across a Statewide ConsortiumDaniel J Herr, Huiying Yin, Steven G Allen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.
Practical Radiation Oncology|February 5, 2022
Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide ConsortiumDaniel J Herr, Kim A Hochstedler, Huiying Yin, et al.
Translational Oncology|April 17, 2016
Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical TrialMichelle M Kim, Hemant Parmar, Yue Cao, et al.
JAMA Oncology|June 2, 2017
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical TrialFeng-Ming Kong, Randall K Ten Haken, Matthew Schipper, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.
Frontiers in Oncology|December 5, 2019
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck CancerYue Cao, Madhava Aryal, Pin Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2016
Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation StudyMichelle M Kim, Sandra Camelo-Piragua, Matthew Schipper, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 30, 2024
Factors associated with acute esophagitis during radiation therapy for lung cancerDaniel J Herr, Huiying Yin, Derek Bergsma, et al.
JNCI Cancer Spectrum|November 17, 2025
Postprostatectomy prostate cancer treated with radiation therapy: adverse features and androgen deprivation therapy use in a statewide consortiumSamuel N Regan, Michael Dykstra, Huiying Yin, et al.
Practical Radiation Oncology|February 8, 2023
Cardiac and Pulmonary Dosimetric Parameters in Patients With Lung Cancer Undergoing Postoperative Radiation Therapy Across a Statewide ConsortiumDaniel J Herr, Huiying Yin, Steven G Allen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.
Practical Radiation Oncology|February 5, 2022
Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide ConsortiumDaniel J Herr, Kim A Hochstedler, Huiying Yin, et al.
Translational Oncology|April 17, 2016
Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical TrialMichelle M Kim, Hemant Parmar, Yue Cao, et al.
JAMA Oncology|June 2, 2017
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical TrialFeng-Ming Kong, Randall K Ten Haken, Matthew Schipper, et al.
Pageof 9